EE05098B1 - Molsidomiini pikendatud vabanemisega oraalne galeeniline ravimvorm - Google Patents

Molsidomiini pikendatud vabanemisega oraalne galeeniline ravimvorm

Info

Publication number
EE05098B1
EE05098B1 EEP200200472A EEP200200472A EE05098B1 EE 05098 B1 EE05098 B1 EE 05098B1 EE P200200472 A EEP200200472 A EE P200200472A EE P200200472 A EEP200200472 A EE P200200472A EE 05098 B1 EE05098 B1 EE 05098B1
Authority
EE
Estonia
Prior art keywords
molsidomine
hours
released
angina
release oral
Prior art date
Application number
EEP200200472A
Other languages
English (en)
Estonian (et)
Inventor
Geczy Jozsef-Michel
Original Assignee
Therabel Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Pharmaceuticals Limited filed Critical Therabel Pharmaceuticals Limited
Publication of EE200200472A publication Critical patent/EE200200472A/xx
Publication of EE05098B1 publication Critical patent/EE05098B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200200472A 2000-02-24 2001-02-22 Molsidomiini pikendatud vabanemisega oraalne galeeniline ravimvorm EE05098B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0002307A FR2805462B1 (fr) 2000-02-24 2000-02-24 Nouvelle forme galenique orale a liberation prolongee de la molsidomine
PCT/EP2001/002055 WO2001062256A1 (fr) 2000-02-24 2001-02-22 Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Publications (2)

Publication Number Publication Date
EE200200472A EE200200472A (et) 2003-12-15
EE05098B1 true EE05098B1 (et) 2008-12-15

Family

ID=8847342

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200472A EE05098B1 (et) 2000-02-24 2001-02-22 Molsidomiini pikendatud vabanemisega oraalne galeeniline ravimvorm

Country Status (36)

Country Link
US (1) US7767227B2 (pt)
EP (1) EP1265614B1 (pt)
JP (1) JP4945043B2 (pt)
KR (1) KR100814191B1 (pt)
CN (1) CN100396284C (pt)
AT (1) ATE296632T1 (pt)
AU (2) AU2001240653B9 (pt)
BE (1) BE1013487A3 (pt)
BG (1) BG66111B1 (pt)
BR (1) BRPI0108041B8 (pt)
CA (1) CA2400886C (pt)
CZ (1) CZ301993B6 (pt)
DE (1) DE60111196T2 (pt)
DZ (1) DZ3273A1 (pt)
EE (1) EE05098B1 (pt)
ES (1) ES2241803T3 (pt)
FR (1) FR2805462B1 (pt)
HK (1) HK1050138B (pt)
HR (1) HRP20020692B1 (pt)
HU (1) HU229799B1 (pt)
IL (2) IL151205A0 (pt)
IS (1) IS2446B (pt)
MA (1) MA25576A1 (pt)
MD (1) MD3119C2 (pt)
MX (1) MXPA02008262A (pt)
NO (1) NO329495B1 (pt)
NZ (1) NZ520691A (pt)
OA (1) OA12183A (pt)
PL (1) PL201631B1 (pt)
PT (1) PT1265614E (pt)
RS (1) RS50291B (pt)
RU (1) RU2263506C2 (pt)
SK (1) SK286313B6 (pt)
UA (1) UA73972C2 (pt)
WO (1) WO2001062256A1 (pt)
ZA (1) ZA200206042B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2868314B1 (fr) * 2004-04-05 2008-10-24 Therabel Pharmaceuticals Ltd Nouvelle utilisation therapeutique de la molsidomine et de ses sels pharmaceutiquement acceptables
EP2468269A1 (en) 2010-11-26 2012-06-27 Universitätsklinikum Münster Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
CN1006522B (zh) * 1986-04-30 1990-01-24 田道制药有限公司 缓放性制剂的制备方法
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
ES2139032T3 (es) * 1993-05-11 2000-02-01 Hoechst Ag Composiciones galenicas a base de molsidomina.
AU7255394A (en) * 1993-07-08 1995-02-06 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE4443105C2 (de) * 1994-12-03 1997-03-13 Hoechst Ag Verfahren zur Herstellung Molsidomin-haltiger Tabletten
JPH09114680A (ja) * 1995-10-19 1997-05-02 Fuji Xerox Co Ltd シーケンス制御装置
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
WO1999013864A2 (en) * 1997-09-19 1999-03-25 Shire Laboratories, Inc. Solid solution beadlet
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Also Published As

Publication number Publication date
PL357550A1 (en) 2004-07-26
FR2805462A1 (fr) 2001-08-31
HUP0300607A2 (hu) 2003-08-28
DE60111196D1 (de) 2005-07-07
IS2446B (is) 2008-11-15
IL151205A (en) 2011-01-31
OA12183A (fr) 2006-05-09
PL201631B1 (pl) 2009-04-30
NO20024043L (no) 2002-08-23
CA2400886A1 (fr) 2001-08-30
CZ301993B6 (cs) 2010-09-01
WO2001062256A1 (fr) 2001-08-30
ZA200206042B (en) 2003-07-29
PT1265614E (pt) 2005-10-31
ES2241803T3 (es) 2005-11-01
IL151205A0 (en) 2003-04-10
MXPA02008262A (es) 2004-04-05
MD20020212A (en) 2002-12-31
FR2805462B1 (fr) 2003-08-15
US20030045522A1 (en) 2003-03-06
BR0108041B1 (pt) 2013-06-18
BG66111B1 (bg) 2011-05-31
KR100814191B1 (ko) 2008-03-17
EE200200472A (et) 2003-12-15
MD3119C2 (ro) 2007-04-30
HRP20020692B1 (en) 2011-10-31
HK1050138A1 (en) 2003-06-13
NZ520691A (en) 2004-07-30
CA2400886C (fr) 2011-04-19
YU62202A (sh) 2006-01-16
AU2001240653B9 (en) 2005-10-27
ATE296632T1 (de) 2005-06-15
MA25576A1 (fr) 2002-10-01
RU2002121503A (ru) 2004-03-20
SK12202002A3 (sk) 2002-12-03
BR0108041A (pt) 2002-10-29
UA73972C2 (en) 2005-10-17
DZ3273A1 (fr) 2001-08-30
BE1013487A3 (fr) 2002-02-05
BRPI0108041B8 (pt) 2021-05-25
NO20024043D0 (no) 2002-08-23
EP1265614B1 (fr) 2005-06-01
HUP0300607A3 (en) 2006-02-28
IS6504A (is) 2002-08-14
RU2263506C2 (ru) 2005-11-10
HK1050138B (zh) 2005-07-29
AU2001240653B2 (en) 2005-05-26
EP1265614A1 (fr) 2002-12-18
MD3119B2 (en) 2006-08-31
CN1419451A (zh) 2003-05-21
HU229799B1 (en) 2014-07-28
RS50291B (sr) 2009-09-08
HRP20020692A2 (en) 2004-02-29
BG107027A (bg) 2003-04-30
JP2003523981A (ja) 2003-08-12
KR20020081323A (ko) 2002-10-26
NO329495B1 (no) 2010-11-01
AU4065301A (en) 2001-09-03
CN100396284C (zh) 2008-06-25
DE60111196T2 (de) 2006-05-11
JP4945043B2 (ja) 2012-06-06
US7767227B2 (en) 2010-08-03
SK286313B6 (en) 2008-07-07

Similar Documents

Publication Publication Date Title
RS115104A (en) Pramipexole once-daily dosage form
DE60121570D1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
CA2601289A1 (en) Once-a-day oxycodone formulations
WO2003072025A3 (en) Modified release formulations of at least one form of tramadol
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
EE05098B1 (et) Molsidomiini pikendatud vabanemisega oraalne galeeniline ravimvorm
PL377683A1 (pl) System terapeutyczny zawierający amoksycylinę i kwas klawulanowy
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
JP2004522780A5 (pt)
ITMI20080798A1 (it) Composizione a rilascio modificato a base di doxofillina
JP2009507850A5 (pt)
HRP20160479T1 (hr) Oralni pripravak molsidomina s produljenim otpuštanjem, namijenjen liječenju ateroskleroze
HUP0401021A2 (hu) Gepiront tartalmazó gyógyászati készítmény orális beadásra

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231